Literature DB >> 7850649

Vibrio vulnificus infection--report of 8 cases and review of cases in Taiwan.

J J Chang1, I S Sheen, S M Peng, P C Chen, C S Wu, H S Leu.   

Abstract

Vibrio vulnificus infection, which is a rare and fatal disease, can be categorized clinically as either primary septicemia or wound infection. The clinical presentation of patients with primary septicemia can vary from fever alone to a more severe illness including high-grade bullous lesions, hypotension, and shock. Wound infection typically results from either injury to the skin in a marine environment or contact of a preexisting wound with sea water. We reported eight cases with Vibrio vulnificus infection in Chang gung Memorial Hospital and reviewed ten other cases previously reported with details in Taiwan. Fourteen patients presented with primary septicemia, and four with wound infection. Thirteen patients had alcoholism or chronic liver disease, two had peptic ulcer disease, one was steroids abuser, and one patient had thalassemia and chronic liver disease. Overall mortality was 55.6% (ten patients). Patients with hypotension within 48 hours of admission had higher mortality than normotensive patients (77% vs. 0%, P = 0.007). Patients with chronic liver disease or liver cirrhosis also had tendency to a higher mortality than not (64% vs. 25%, P = 0.274). Chronic liver diseases and liver cirrhosis are common disease in Taiwan. They take a high risk for Vibrio vulnificus infection. Clinician should keep in mind of this potentially fatal infection in these patients reporting a history of recent raw oyster consumption and presented with sepsis and characterized skin lesions. Prompt empirical antibiotics treatment and aggressive surgical treatment may be lifesaving for this acute and fatal disease.

Entities:  

Mesh:

Year:  1994        PMID: 7850649

Source DB:  PubMed          Journal:  Changgeng Yi Xue Za Zhi


  8 in total

1.  Does Vibrio vulnificus present a health threat to Canadians?

Authors:  S Stavric; B Buchanan
Journal:  Can J Infect Dis       Date:  1997-09

2.  In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus.

Authors:  Y C Chuang; J W Liu; W C Ko; K Y Lin; J J Wu; K Y Huang
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

3.  Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection.

Authors:  Y C Chuang; W C Ko; S T Wang; J W Liu; C F Kuo; J J Wu; K Y Huang
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

4.  Vibrio vulnificus Diarrhea in a Child with Respiratory Infection.

Authors:  Anuradha De; M Mathur
Journal:  J Glob Infect Dis       Date:  2011-07

Review 5.  Vibrio vulnificus in Taiwan.

Authors:  Po-Ren Hsueh; Ching-Yih Lin; Hung-Jen Tang; Hsin-Chun Lee; Jien-Wei Liu; Yung-Ching Liu; Yin-Ching Chuang
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

Review 6.  Vibrio vulnificus: An Environmental and Clinical Burden.

Authors:  Sing-Peng Heng; Vengadesh Letchumanan; Chuan-Yan Deng; Nurul-Syakima Ab Mutalib; Tahir M Khan; Lay-Hong Chuah; Kok-Gan Chan; Bey-Hing Goh; Priyia Pusparajah; Learn-Han Lee
Journal:  Front Microbiol       Date:  2017-05-31       Impact factor: 5.640

Review 7.  Distribution of Fatal Vibrio Vulnificus Necrotizing Skin and Soft-Tissue Infections: A Systematic Review and Meta-Analysis.

Authors:  Kuo-Chin Huang; Hsu-Huei Weng; Tien-Yu Yang; Te-Sheng Chang; Tsan-Wen Huang; Mel S Lee
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

8.  Hepatic disease and the risk of mortality of Vibrio vulnificus necrotizing skin and soft tissue infections: A systematic review and meta-analysis.

Authors:  Po-Yao Chuang; Tien-Yu Yang; Tsan-Wen Huang; Yao-Hung Tsai; Kuo-Chin Huang; Hsu-Huei Weng
Journal:  PLoS One       Date:  2019-10-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.